Hidden cancer risks for Hysterectomy and Fibroid Removal

Uterine cancer is the fourth most common cancer in women in the United States and the most commonly diagnosed gynecologic cancer[1]. Prior to a hysterectomy or fibroid removal (myomectomy), the FDA estimates that approximately 1 in 350 women have an unsuspected uterine sarcoma, a type of uterine cancer that includes leiomyosarcoma.[2] Stages of Endometrial...

read more

J&J Pulls Hysterectomy Tool Due to Cancer Risk

Johnson & Johnson has asked all hospitals to return a surgical device that can spread cancer in women being treated for uterine growths called fibroids. The company has instituted a voluntary “worldwide market withdrawal” of the surgical tool known as a laparoscopic power morcellator. During laparoscopic hysterectomies and myomectomies, surgeons use a power morcellator...

read more

Fibroid Treatment May Spread Hidden Cancer

The FDA has issued a warning that certain surgical procedures used to treat uterine fibroids can cause the spread of undetected cancer. What are Fibroids? A uterine fibroid is a tumor that grows in the wall of the uterus. While many women who develop fibroids experience no symptoms, those who do may require surgery...

read more